Puretech Health Plc Stock Market Outlook
| PRTC Stock | USD 17.46 0.15 0.85% |
About 62% of PureTech Health's investor base is looking to short. The analysis of the overall investor sentiment regarding PureTech Health PLC suggests that many traders are alarmed. The current market sentiment, together with PureTech Health's historical and current headlines, can help investors time the market. In addition, many technical investors use PureTech Health PLC stock news signals to limit their universe of possible portfolio assets.
Comfort Level 38
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use PureTech Health's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward PureTech Health PLC.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding PureTech Health PLC is 'Buy'. Macroaxis provides PureTech Health buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PRTC positions.
Execute PureTech Health Advice
The PureTech recommendation should be used to complement the investment advice compiled from the current analysts' consensus on PureTech Health PLC. Macroaxis does not own or have any residual interests in PureTech Health PLC or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute PureTech Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Market Performance | Mild | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon PureTech Health PLC has a Risk Adjusted Performance of 0.0168, Jensen Alpha of (0), Total Risk Alpha of (0.18), Sortino Ratio of (0.01) and Treynor Ratio of 0.0556Our trade recommendations tool can cross-verify current analyst consensus on PureTech Health PLC and to analyze the firm potential to grow in the current economic cycle. To make sure PureTech Health is not overpriced, please check all PureTech Health PLC fundamentals, including its ebitda, cash flow from operations, retained earnings, as well as the relationship between the total debt and number of employees . Given that PureTech Health PLC has a number of shares shorted of 3.86 K, we recommend you to check out PureTech Health PLC market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.
PureTech Health Trading Alerts and Improvement Suggestions
| PureTech Health PLC currently holds about 368.03 M in cash with (134.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. |
PureTech Health Returns Distribution Density
The distribution of PureTech Health's historical returns is an attempt to chart the uncertainty of PureTech Health's future price movements. The chart of the probability distribution of PureTech Health daily returns describes the distribution of returns around its average expected value. We use PureTech Health PLC price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of PureTech Health returns is essential to provide solid investment analysis for PureTech Health.
| Mean Return | 0.03 | Value At Risk | -4.58 | Potential Upside | 4.38 | Standard Deviation | 2.74 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of PureTech Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
PureTech Stock Institutional Investors
| Shares | Birch Hill Investment Advisors Llc | 2025-06-30 | 242.7 K | Pentwater Capital Management Lp | 2025-06-30 | 50 K | Portolan Capital Management, Llc | 2025-06-30 | 27.8 K | Millennium Management Llc | 2025-06-30 | 23.9 K | Diadema Partners Lp | 2025-06-30 | 7.3 K | Persistent Asset Partners Limited | 2025-06-30 | 1.7 K | Atlantic Union Bankshares Corp | 2025-06-30 | 115 | Ubs Group Ag | 2025-06-30 | 20.0 | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 0.0 |
PureTech Health Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | 61.8M | (315.8M) | 41.2M | 89.6M | 80.6M | 84.6M | |
| Free Cash Flow | (163.9M) | (181.0M) | (106.2M) | (134.4M) | (120.9M) | (127.0M) | |
| Depreciation | 7.3M | 8.9M | 4.9M | 3.6M | 4.1M | 3.9M | |
| Other Non Cash Items | (5.1M) | (111.1M) | (67.1M) | (178.3M) | (160.5M) | (152.5M) | |
| Capital Expenditures | 5.7M | 2.2M | 245K | 11K | 12.7K | 12.0K | |
| Net Income | (62.7M) | (37.1M) | (65.7M) | 27.8M | 31.9M | 33.5M | |
| End Period Cash Flow | 465.7M | 149.9M | 191.1M | 280.6M | 322.7M | 176.9M | |
| Investments | 217.6M | (107.2M) | 69.0M | 240.9M | 277.0M | 290.9M |
PureTech Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to PureTech Health or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that PureTech Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a PureTech stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.0018 | |
β | Beta against Dow Jones | 0.42 | |
σ | Overall volatility | 2.64 | |
Ir | Information ratio | -0.01 |
PureTech Health Volatility Alert
PureTech Health PLC shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure PureTech Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact PureTech Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.PureTech Health Fundamentals Vs Peers
Comparing PureTech Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze PureTech Health's direct or indirect competition across all of the common fundamentals between PureTech Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as PureTech Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of PureTech Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing PureTech Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare PureTech Health to competition |
| Fundamentals | PureTech Health | Peer Average |
| Return On Equity | 0.0944 | -0.31 |
| Return On Asset | -0.13 | -0.14 |
| Profit Margin | 7.93 % | (1.27) % |
| Operating Margin | (25.90) % | (5.51) % |
| Current Valuation | 123.25 M | 16.62 B |
| Shares Outstanding | 24.17 M | 571.82 M |
| Shares Owned By Institutions | 0.42 % | 39.21 % |
| Number Of Shares Shorted | 3.86 K | 4.71 M |
| Price To Book | 1.12 X | 9.51 X |
| Price To Sales | 66.03 X | 11.42 X |
| Revenue | 4.83 M | 9.43 B |
| Gross Profit | (48.81 M) | 27.38 B |
| EBITDA | 37.38 M | 3.9 B |
| Net Income | 27.78 M | 570.98 M |
| Cash And Equivalents | 368.03 M | 2.7 B |
| Cash Per Share | 12.84 X | 5.01 X |
| Total Debt | 22.36 M | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 2.54 X | 2.16 X |
| Book Value Per Share | 1.56 X | 1.93 K |
| Cash Flow From Operations | (134.37 M) | 971.22 M |
| Short Ratio | 1.36 X | 4.00 X |
| Earnings Per Share | 1.70 X | 3.12 X |
| Target Price | 46.0 | |
| Number Of Employees | 56 | 18.84 K |
| Beta | 0.72 | -0.15 |
| Market Capitalization | 421.98 M | 19.03 B |
| Total Asset | 602.63 M | 29.47 B |
| Retained Earnings | 32.49 M | 9.33 B |
| Working Capital | 344.87 M | 1.48 B |
| Net Asset | 602.63 M |
PureTech Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as PureTech . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 17.46 | |||
| Day Typical Price | 17.46 | |||
| Price Action Indicator | (0.07) | |||
| Period Momentum Indicator | (0.15) |
About PureTech Health Buy or Sell Advice
When is the right time to buy or sell PureTech Health PLC? Buying financial instruments such as PureTech Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having PureTech Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run IT Thematic Idea Now
IT
Information Technology (IT) companies and IT service providers across different domains. The IT theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize IT Theme or any other thematic opportunities.
| View All Next | Launch |
Check out PureTech Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Will Biotechnology sector continue expanding? Could PureTech diversify its offerings? Factors like these will boost the valuation of PureTech Health. Anticipated expansion of PureTech directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PureTech Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.615 | Earnings Share 1.7 | Revenue Per Share | Quarterly Revenue Growth 5.427 | Return On Assets |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between PureTech Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PureTech Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PureTech Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.